Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study-Reference-Cited by-同舟云学术

Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study

Published:2018-01 Issue: Volume:86 Page:1-8
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Iaccarino Luca,Andreoli Laura^ORCID,Bocci Elena Bartoloni,Bortoluzzi Alessandra,Ceccarelli Fulvia,Conti Fabrizio,De Angelis Rossella,De Marchi Ginevra,De Vita Salvatore,Di Matteo Andrea^ORCID,Emmi Giacomo,Emmi Lorenzo,Gatto Mariele,Gerli Roberto,Gerosa Maria,Govoni Marcello^ORCID,Larosa Maddalena,Meroni Pier Luigi,Mosca Marta,Pazzola Giulia,Reggia Rossella,Saccon Francesca,Salvarani Carlo,Tani Chiara,Zen Margherita,Frigo Anna Chiara^ORCID,Tincani Angela,Doria Andrea

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference50 articles.

1. Long-term prognosis and causes of death in systemic lupus erythematosus;Doria;Am. J. Med.,2006

2. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study;Zen;Clin. Exp. Rheumatol.,2012

3. Prolonged remission in Caucasian patients with SLE: prevalence and outcomes;Zen;Ann. Rheum. Dis.,2015

4. Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus;Nossent;Lupus,2010

5. Premature coronary heart disease in SLE: can we prevent progression?;Iaccarino;Lupus,2013

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of SLE treatment: An expert viewpoint on the rationality and limitations of early biologic intervention;Autoimmunity Reviews;2024-08

2. Monoclonal antibodies targeting interleukins for systemic lupus erythematosus: updates in early clinical drug development;Expert Opinion on Investigational Drugs;2024-07-09

3. Novedades en la inmunoterapia de las enfermedades autoinmunes del tejido conectivo. Parte I: lupus eritematoso cutáneo;Piel;2024-07

4. Frequency and predictors for early-achieved lupus low disease activity state in systemic lupus erythematosus patients treated with telitacicept or belimumab: A real-life, single-center observational study;Frontiers in Immunology;2024-06-14

5. The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study;Lupus;2024-03-22